Location History:
- Sakai, JP (2009)
- Chiyoda-ku, JP (2019 - 2021)
Company Filing History:
Years Active: 2009-2021
Title: The Innovative Contributions of Takamasa Sugita
Introduction
Takamasa Sugita, an accomplished inventor based in Chiyoda-ku, Japan, is known for his significant contributions to the field of medicinal chemistry. With a total of four patents to his name, Sugita has focused on developing therapeutic agents that address various health disorders, showcasing his dedication to innovation and public health.
Latest Patents
One of Sugita's latest patents highlights a production method of a thiazole derivative, which possesses adenosine A receptor antagonistic action. This derivative is particularly useful as a therapeutic agent for conditions such as Parkinson's disease, sleep disorders, analgesic resistance to opioids, migraines, movement disorders, depression, and anxiety disorders. The production method includes steps that involve reacting specific chemical compounds, represented by an intricate formula, to yield the desired thiazole derivative.
Career Highlights
Throughout his career, Sugita has worked with notable organizations, including Kyowa Kirin Co., Ltd. and Kyowa Hakko Kirin Co., Limited. At these companies, he has advanced the field of drug development, focusing on innovative solutions for unmet medical needs. His dedication to research and development has played a pivotal role in propelling therapeutic advancements.
Collaborations
Takamasa Sugita has also collaborated with respected colleagues, such as Arata Yanagisawa and Iwao Chujo. These partnerships have enabled Sugita to leverage diverse expertise and insights, further enhancing his innovative capabilities and contributing to the success of his research projects.
Conclusion
In summary, Takamasa Sugita stands out as a prominent inventor within the field of medicinal chemistry. His work on thiazole derivatives demonstrates his commitment to addressing significant health challenges. Through collaboration and innovative thinking, Sugita continues to impact the landscape of pharmaceutical advancements, paving the way for improved therapeutic options for patients worldwide.